289 related articles for article (PubMed ID: 32358791)
1. SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor.
Balestri R; Rech G; Girardelli CR
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e357-e358. PubMed ID: 32358791
[No Abstract] [Full Text] [Related]
2. Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient.
Benhadou F; Del Marmol V
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e363-e364. PubMed ID: 32379925
[No Abstract] [Full Text] [Related]
3. COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.
Mugheddu C; Pizzatti L; Sanna S; Atzori L; Rongioletti F
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e376-e378. PubMed ID: 32385859
[No Abstract] [Full Text] [Related]
4. COVID-19 and dermatology: a comprehensive guide for dermatologists.
Fahmy DH; El-Amawy HS; El-Samongy MA; Fouda AA; Soliman SH; El-Kady A; Farnetani F; Conti A; Zoeir A; Eissa A; Eissa R; Puliatti S; Sighinolfi MC; Rocco B; Pellacani G
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1388-1394. PubMed ID: 32428303
[No Abstract] [Full Text] [Related]
5. Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs.
Conti A; Lasagni C; Bigi L; Pellacani G
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e360-e361. PubMed ID: 32379913
[No Abstract] [Full Text] [Related]
6. Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era.
Galluzzo M; Tofani L; Bianchi L; Talamonti M
Expert Opin Biol Ther; 2020 Aug; 20(8):829-830. PubMed ID: 32510244
[TBL] [Abstract][Full Text] [Related]
7. Guttate psoriasis secondary to COVID-19.
Gananandan K; Sacks B; Ewing I
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32784237
[No Abstract] [Full Text] [Related]
8. SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.
Caroppo F; Biolo G; Belloni Fortina A
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e368. PubMed ID: 32386431
[No Abstract] [Full Text] [Related]
9. Should biologics for psoriasis be interrupted in the era of COVID-19?
Lebwohl M; Rivera-Oyola R; Murrell DF
J Am Acad Dermatol; 2020 May; 82(5):1217-1218. PubMed ID: 32199889
[No Abstract] [Full Text] [Related]
10. The diabetic lung: An easy target for SARS-CoV-2?
Caruso I; Giorgino F
Diabetes Metab Res Rev; 2020 Nov; 36(8):e3346. PubMed ID: 32426928
[No Abstract] [Full Text] [Related]
11. Covid-19 infection in psoriasis patients treated with cyclosporin.
Di Lernia V; Goldust M; Feliciani C
Dermatol Ther; 2020 Jul; 33(4):e13739. PubMed ID: 32478942
[No Abstract] [Full Text] [Related]
12. Symmetric cutaneous vasculitis in COVID-19 pneumonia.
Castelnovo L; Capelli F; Tamburello A; Faggioli PM; Mazzone A
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e362-e363. PubMed ID: 32378747
[No Abstract] [Full Text] [Related]
13. The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.
Wan MT; Shin DB; Winthrop KL; Gelfand JM
J Am Acad Dermatol; 2020 Aug; 83(2):677-679. PubMed ID: 32416207
[No Abstract] [Full Text] [Related]
14. SARS-CoV-2 infection presenting as a febrile rash.
Amatore F; Macagno N; Mailhe M; Demarez B; Gaudy-Marqueste C; Grob JJ; Raoult D; Brouqui P; Richard MA
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e304-e306. PubMed ID: 32330336
[No Abstract] [Full Text] [Related]
15. Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.
Janah H; Zinebi A; Elbenaye J
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e373-e375. PubMed ID: 32386446
[No Abstract] [Full Text] [Related]
16. Cutaneous manifestation of COVID-19 in images: a case report.
Avellana Moreno R; Estela Villa LM; Avellana Moreno V; Estela Villa C; Moreno Aparicio MA; Avellana Fontanella JA
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e307-e309. PubMed ID: 32330339
[No Abstract] [Full Text] [Related]
17. Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient.
Locatelli AG; Robustelli Test E; Vezzoli P; Carugno A; Moggio E; Consonni L; Gianatti A; Sena P
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):e365-e368. PubMed ID: 32386459
[No Abstract] [Full Text] [Related]
18. Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports.
Ferrucci S; Romagnuolo M; Angileri L; Berti E; Tavecchio S
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e303-e304. PubMed ID: 32330323
[No Abstract] [Full Text] [Related]
19. SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis.
Vischini G; D'Alonzo S; Grandaliano G; D'Ascenzo FM
Kidney Int; 2020 Jul; 98(1):237-238. PubMed ID: 32413379
[No Abstract] [Full Text] [Related]
20. COVID-19 and sickle cell disease.
Menapace LA; Thein SL
Haematologica; 2020 Nov; 105(11):2501-2504. PubMed ID: 33131239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
